Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 170 of 1,261
  1. US 11759525

    Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  2. US 11760858

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  3. US 11759531

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  4. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  5. US 11761006

    Use of MIR101 or MIR128 in the treatment of seizure disorders

    OVID THERAPEUTICS INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  6. CA 3244873

    TRAITEMENT PRÉVENTIF DE LA MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Sep 14, 2023 · Expires Sep 9, 2043

    granted
  7. US 11753655

    Compositions and methods for treatment of neurological disorders

    The Board of Regents of the University of Texas System · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  8. US 11752106

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  9. US 11752190

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  10. US 11752195

    Compositions and methods of use of synthetic peptides with Mycobacterium abscessus inhibitory activity

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  11. US 11753444

    Modulation of structured polypeptide specificity

    BicycleRD Limited · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  12. US 11753369

    Creatine prodrugs, compositions and methods of use thereof

    Ultragenyx Pharmaceutical Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  13. US 11753377

    Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

    ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  14. US 11753398

    Therapeutic compounds

    C4X Discovery Limited · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  15. US 11753397

    Cereblon binders for the degradation of ikaros

    C4 THERAPEUTICS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  16. US 11753443

    Conjugated hepcidin mimetics

    Protagonist Therapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  17. US 11753408

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  18. US 11753461

    Optimized factor VIII genes

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  19. US 11753459

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  20. US 11753466

    Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  21. US 11753474

    Anti-Dectin-2 antibodies

    Bolt Biotherapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  22. US 11753630

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Precision BioSciences, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  23. US 11753623

    Compositions for treating retinal diseases and methods for making and using them

    The Regents of the University of California · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  24. US 11753628

    HSD17B13 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.